Insilico Medicine
UnclaimedAccelerating drug discovery and development through generative AI and automation for longevity and sustainability.
Visit WebsitePaidVisit Website
TL;DR - Insilico Medicine
- Uses generative AI to accelerate drug discovery and development.
- Proprietary Pharma.AI platform covers biology, chemistry, and clinical stages.
- Aims to reduce time and cost in bringing new medications to market.
Pricing: Paid only
Best for: Enterprises & pros
What is Insilico Medicine?
Insilico Medicine is an end-to-end generative AI-driven biotech company that transforms drug discovery and development. It leverages its proprietary Pharma.AI platform, which encompasses biology, chemistry, and clinical development, to significantly reduce the time and cost associated with bringing new medications to patients. The platform utilizes generative AI to identify novel targets, design new molecules, and advance a self-generated pipeline of drug candidates.
The company's offerings include specific AI software products like PandaOmics, Chemistry42, Generative Biologics, and Science42:DORA, which are available for licensing. These tools support various stages of drug discovery, from target identification and hit-to-lead optimization to IND-enabling studies and clinical trials. Insilico Medicine's mission is to extend healthy, productive longevity for everyone by making drug discovery more efficient and accessible.
Available on: Web
Pros & Cons
Pros
- Significantly reduces time and cost in drug discovery
- Accelerates the development of life-saving medications
- Leverages cutting-edge generative AI and automation
- Comprehensive platform covering multiple stages of drug development
- Strong external validation through collaborations with top pharmaceutical companies
Cons
- No explicit pricing information available on the website
- Requires specialized knowledge in drug discovery and AI to fully utilize
- Specific product details for each software (e.g., PandaOmics) are not fully elaborated on the main pages
Preview
Key Features
Generative AI for target identification and novel molecule designAutomation for drug discovery and development processesProprietary Pharma.AI platform (biology, chemistry, clinical development)PandaOmics for target discovery and drug repurposingChemistry42 for de novo molecular designGenerative Biologics for biologics designScience42:DORA for clinical trial design and optimizationLarge Language of Life Models (LLLMs) and LLM Assistant
Pricing
Paid
Insilico Medicine offers paid plans. Visit their website for current pricing details.
Reviews
Be the first to review Insilico Medicine
Your take helps the next buyer. Verified LinkedIn reviewers get a badge.
Write a reviewBest Insilico Medicine Alternatives
Top alternatives based on features, pricing, and user needs.
Mistral AIFreemium
Efficient, open-weight LLMs from Europe for your AI apps
Hugging FaceFreemium
Open-source AI models, datasets, and tools for collaborative ML
4Moving BiotechPaid
Translating scientific discoveries into medical solutions for patients.
Ambros TherapeuticsPaid
Developing breakthrough therapies for rare diseases with high unmet medical needs.
Kinaset TherapeuticsPaid
Developing inhaled therapeutics for severe respiratory diseases.
Lexicon Pharmaceuticals, Inc.Freemium
Developing innovative therapies for chronic and debilitating diseases.
Beactica TherapeuticsPaid
Developing novel small molecule therapeutics for life-threatening diseases.
SanegeneBioFreemium
Advancing bioinformatics solutions for life science research and drug discovery.
Explore More
Insilico Medicine FAQ
How does Insilico Medicine accelerate drug discovery?
Insilico Medicine accelerates drug discovery by using its proprietary Pharma.AI platform, which leverages generative AI across biology, chemistry, and clinical development. This platform identifies novel targets, designs new molecules, and advances drug candidates, significantly reducing the time and cost involved.
Which teams would benefit most from Insilico Medicine's platform?
Teams involved in pharmaceutical research and development, particularly those focused on drug discovery, bioinformatics, and AI-driven scientific research, would benefit most. The platform is designed for biotech companies and research institutions aiming to streamline their drug development pipelines.
How does Insilico Medicine compare to Starget Pharma?
Insilico Medicine differentiates itself by offering an end-to-end generative AI-driven platform covering biology, chemistry, and clinical development, with specific AI software products available for licensing. It focuses on accelerating drug discovery and development through comprehensive AI and automation, whereas Starget Pharma's specific approach is not detailed here.
What kind of specialized knowledge is needed to utilize Insilico Medicine effectively?
To fully utilize Insilico Medicine's platform, users require specialized knowledge in both drug discovery and artificial intelligence. This ensures effective application of its AI software products like PandaOmics and Chemistry42 in various stages of drug development.
How is Insilico Medicine priced?
Insilico Medicine is offered as a paid product, meaning there is no permanently free tier available. Its AI software products, such as PandaOmics and Chemistry42, are available for licensing.
Can Insilico Medicine assist with target identification in drug development?
Yes, Insilico Medicine can assist with target identification through its Pharma.AI platform, which utilizes generative AI to identify novel targets. This is a core capability designed to support the early stages of drug discovery.
Source: insilico.com